Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M J Nuijten

Showing results (1-10 of 15) with videos related to

Pageof 2
Sort By:
Value in Health : the Journal of the International Society for Pharmacoeconomics and Outcomes Research|November 14, 2001
Assessment of clinical guidelines for continuation treatment in major depressionM J Nuijten
Value in Health : the Journal of the International Society for Pharmacoeconomics and Outcomes Research|May 6, 2006
Pharmacoeconomics in European decision-makingM J Nuijten
Pharmacoeconomics|October 28, 1999
Measuring sensitivity in pharmacoeconomic studies. Refining point sensitivity and range sensitivity by incorporating probability distributionsM J Nuijten
Pharmacoeconomics|August 18, 2000
Bridging decision analytic modelling with a cross-sectional study. Application to Parkinson's diseaseM J Nuijten
Pharmacoeconomics|February 6, 1998
The selection of data sources for use in modelling studiesM J Nuijten
Pharmacoeconomics|February 6, 1998
Applications of modelling studiesM J Nuijten, J Starzewski
Pharmacoeconomics|October 4, 1997
Measuring sensitivity in pharmacoeconomic studies. An integration of point-sensitivity and range-sensitivityM J Nuijten, M Hardens
Pharmacoeconomics|July 7, 1995
A Markov process analysis comparing the cost effectiveness of maintenance therapy with citalopram versus standard therapy in major depressionM J Nuijten, M Hardens, E Souêtre
Pharmacoeconomics|April 17, 2001
Cost effectiveness of emedastine versus levocabastine in the treatment of allergic conjunctivitis in 7 European countriesC G Pinto, A Lafuma, F Fagnani, et al.
Pharmacoeconomics|December 12, 2001
A cost-cost study comparing etanercept with infliximab in rheumatoid arthritisM J Nuijten, P Engelfriet, K Duijn, et al.
Pageof 2

Showing results (1-10 of 15) with videos related to

Sort By:
Pageof 2
Value in Health : the Journal of the International Society for Pharmacoeconomics and Outcomes Research|November 14, 2001
Assessment of clinical guidelines for continuation treatment in major depressionM J Nuijten
Value in Health : the Journal of the International Society for Pharmacoeconomics and Outcomes Research|May 6, 2006
Pharmacoeconomics in European decision-makingM J Nuijten
Pharmacoeconomics|October 28, 1999
Measuring sensitivity in pharmacoeconomic studies. Refining point sensitivity and range sensitivity by incorporating probability distributionsM J Nuijten
Pharmacoeconomics|August 18, 2000
Bridging decision analytic modelling with a cross-sectional study. Application to Parkinson's diseaseM J Nuijten
Pharmacoeconomics|February 6, 1998
The selection of data sources for use in modelling studiesM J Nuijten
Pharmacoeconomics|February 6, 1998
Applications of modelling studiesM J Nuijten, J Starzewski
Pharmacoeconomics|October 4, 1997
Measuring sensitivity in pharmacoeconomic studies. An integration of point-sensitivity and range-sensitivityM J Nuijten, M Hardens
Pharmacoeconomics|July 7, 1995
A Markov process analysis comparing the cost effectiveness of maintenance therapy with citalopram versus standard therapy in major depressionM J Nuijten, M Hardens, E Souêtre
Pharmacoeconomics|April 17, 2001
Cost effectiveness of emedastine versus levocabastine in the treatment of allergic conjunctivitis in 7 European countriesC G Pinto, A Lafuma, F Fagnani, et al.
Pharmacoeconomics|December 12, 2001
A cost-cost study comparing etanercept with infliximab in rheumatoid arthritisM J Nuijten, P Engelfriet, K Duijn, et al.
Pageof 2